ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 577,90
-0,72%
Dow Jones
40 211,72
0,53%
DAX
18 517,43
-0,44%
Brent Oil
83,565
-0,92%
Bitcoin
63 441,42
-2,17%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Portola Pharmaceuticals Inc (PTLA)

  7. Portola Pharmaceuticals Inc (PTLA) Actualités

PTLA

Portola Pharmaceuticals (PTLA)

Portola Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PTLA
DateHeureSourceTitreSymboleSociété
09/01/201514h00GlobeNewswire Inc.Portola Announces Phase 3 ANNEXA-R Study of Andexanet Alfa and Factor Xa Inhibitor XARELTO(R) (rivaroxaban) Met Primary Endpo...NASDAQ:PTLAPortola Pharmaceuticals Inc
06/01/201522h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Webcast of Corporate Presentation on January 12, 2015NASDAQ:PTLAPortola Pharmaceuticals Inc
31/12/201415h52Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:PTLAPortola Pharmaceuticals Inc
25/11/201423h54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTLAPortola Pharmaceuticals Inc
10/11/201422h17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTLAPortola Pharmaceuticals Inc
03/10/201412h08Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PTLAPortola Pharmaceuticals Inc
01/10/201422h09Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:PTLAPortola Pharmaceuticals Inc
06/08/201423h27Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTLAPortola Pharmaceuticals Inc
30/07/201422h00GlobeNewswire Inc.Portola Pharmaceuticals to Announce Second Quarter 2014 Financial Results and Host Conference Call on Wednesday, August 6, 20...NASDAQ:PTLAPortola Pharmaceuticals Inc
10/07/201418h12Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PTLAPortola Pharmaceuticals Inc
07/07/201420h10GlobeNewswire Inc.Portola Pharmaceuticals Enters Into Clinical Collaboration Agreement With Daiichi Sankyo for Phase 3 Studies of Factor Xa Inh...NASDAQ:PTLAPortola Pharmaceuticals Inc
12/06/201422h00GlobeNewswire Inc.Portola Pharmaceuticals to Present at the 2014 Wells Fargo Securities Healthcare ConferenceNASDAQ:PTLAPortola Pharmaceuticals Inc
11/06/201414h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Positive Phase 2 Data With FDA-Designated Breakthrough Therapy Andexanet Alfa and Enoxapari...NASDAQ:PTLAPortola Pharmaceuticals Inc
14/05/201423h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Two Presentations of Data on Cerdulatinib, an Oral Dual Syk/JAK Inhibitor, at 2014 ASCO Ann...NASDAQ:PTLAPortola Pharmaceuticals Inc
12/05/201423h23Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PTLAPortola Pharmaceuticals Inc
12/05/201422h02GlobeNewswire Inc.Portola Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate UpdateNASDAQ:PTLAPortola Pharmaceuticals Inc
12/05/201414h00GlobeNewswire Inc.Portola Pharmaceuticals Begins Enrollment in Phase 3 Study of FDA-Designated Breakthrough Therapy Andexanet Alfa and Factor X...NASDAQ:PTLAPortola Pharmaceuticals Inc
12/05/201413h55GlobeNewswire Inc.Portola Pharmaceuticals to Present at Bank of America Merrill Lynch 2014 Health Care ConferenceNASDAQ:PTLAPortola Pharmaceuticals Inc
05/05/201414h00GlobeNewswire Inc.Portola Pharmaceuticals to Announce First Quarter 2014 Financial Results and Host Conference Call on Monday, May 12, 2014NASDAQ:PTLAPortola Pharmaceuticals Inc
14/04/201414h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Publication of Phase 3 APEX Study Design and Rationale in American Heart JournalNASDAQ:PTLAPortola Pharmaceuticals Inc
09/04/201414h00PR Newswire (US)Enrollment in Expansion Phase of Trials, Results and Initiation of Phase 2 Studies and Stock Movements - Analyst Notes on Pfi...NASDAQ:PTLAPortola Pharmaceuticals Inc
04/04/201412h38Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PTLAPortola Pharmaceuticals Inc
04/04/201412h31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PTLAPortola Pharmaceuticals Inc
27/03/201423h59Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PTLAPortola Pharmaceuticals Inc
27/03/201413h00GlobeNewswire Inc.Portola Pharmaceuticals Initiates Phase 2 Study of Andexanet Alfa, Potential First-in-Class Factor Xa Inhibitor Reversal Agen...NASDAQ:PTLAPortola Pharmaceuticals Inc
19/03/201413h00GlobeNewswire Inc.Portola Pharmaceuticals Initiates Phase 3 Study of Andexanet Alfa, Potential First-in-Class Factor Xa Inhibitor Reversal Agen...NASDAQ:PTLAPortola Pharmaceuticals Inc
18/03/201413h00GlobeNewswire Inc.Portola Pharmaceuticals Appoints John H. Johnson to Board of DirectorsNASDAQ:PTLAPortola Pharmaceuticals Inc
05/03/201414h32PR Newswire (US)Quarterly and Annual Financial Results Release, Executive Appointments, Upcoming Conferences, and Promotion Announcements - A...NASDAQ:PTLAPortola Pharmaceuticals Inc
03/03/201416h17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PTLAPortola Pharmaceuticals Inc
27/02/201422h01GlobeNewswire Inc.Portola Pharmaceuticals Reports Fourth Quarter and Year-End 2013 Financial Results and Provides Corporate UpdateNASDAQ:PTLAPortola Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PTLA

Dernières Valeurs Consultées

LSE
0RSP
Ayvens
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés